SPK-8011QQ

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPK-8011QQ, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A [Phase 1, Phase 2]